Effects of antioxidant supplementation on postprandial oxidative stress and endothelial dysfunction: a single-blind, 15-day clinical trial in patients with untreated type 2 diabetes, subjects with impaired glucose tolerance, and healthy controls
- PMID: 16368447
- DOI: 10.1016/j.clinthera.2005.11.006
Effects of antioxidant supplementation on postprandial oxidative stress and endothelial dysfunction: a single-blind, 15-day clinical trial in patients with untreated type 2 diabetes, subjects with impaired glucose tolerance, and healthy controls
Abstract
Background: Increased generation of reactive oxygen species (ROS) and oxidative stress may be of crucial importance in the pathogenesis of endothelial damage. Furthermore, there is understood to be a relationship between endothelial damage, glycemic control, disorders of lipid metabolism, and coagulative hemostatic disorders.
Objective: This study investigated within- and between-group changes in various circulating markers of oxidation-reduction balance and endothelial function after a balanced moderate-fat meal with and without antioxidant supplementation in patients with early-stage, untreated type 2 diabetes mellitus; subjects with impaired glucose tolerance (IGT); and healthy controls.
Methods: In this single-blind, controlled clinical study, groups of patients with type 2 diabetes and subjects with IGT were identified and compared with a group of healthy controls. All groups followed a controlled, well-balanced diet for 10 days before and throughout the study. Before and after consumption of a standardized moderate-fat meal, plasma levels of oxidants (malondialdehyde, 4-hydroxynonenal, oxidized low-density lipoprotein), the antioxidant glutathione peroxidase, and markers of endothelial function (NO, endothelin-1, von Willebrand factor [vWF], vascular cell adhesion molecule-1 [VCAM-1]) were determined. These measures were then reassessed after 15 days of standard antioxidant treatment consisting of a thiol-containing antioxidant (N-acetylcysteine 600 g/d), a bound antioxidant (vitamin E 300 g/d), and an aqueous phase antioxidant (vitamin C 250 mg/d). The efficacy of antioxidant treatment in reversing abnormalities in oxidation-reduction balance after a moderate-fat meal was assessed by evaluating changes in plasma levels of ROS on the morning of the 16th day following an overnight fast. Safety was monitored in terms of adverse events, vital signs, physical findings, and laboratory values.
Results: The study included 46 patients with type 2 diabetes (23 men, 23 women; mean [SD] age, 41 [3] years; mean body mass index [BMI], 24 [2] kg/m(2)), 46 with IGT (23 men, 23 women; mean age, 39 [3] years; mean BMI, 23 [3] kg/m(2)), and 46 control subjects (23 men, 23 women; mean age, 40 [1] years; mean BMI, 22 [1] kg/m(2)). Before supplementation, all 3 groups had significantly increased levels of oxidants, vWF, and VCAM-1 (all, P < 0.001) and significantly decreased levels of antioxidants and NO (both, P < 0.001) after consumption of a moderate-fat meal. After 15 days of antioxidant treatment, significant improvements in these measures were seen in all groups (P < 0.05).
Conclusions: This study showed changes in oxidation-reduction balance, NO bioavailability, and nonthrombogenic endothelial factors after a moderate-fat meal in patients with type 2 diabetes and those with IGT, but these postprandial changes were reverse in all subjects after 15 days of standard antioxidant supplementation. These findings suggest that the use of anti-oxidants may have decreased oxidative stress in these subjects.
Similar articles
-
Prolonged deterioration of endothelial dysfunction in response to postprandial lipaemia is attenuated by vitamin C in Type 2 diabetes.Diabet Med. 2006 Mar;23(3):258-64. doi: 10.1111/j.1464-5491.2005.01767.x. Diabet Med. 2006. PMID: 16492208
-
Effects of vitamins C and E on oxidative stress markers and endothelial function in patients with systemic lupus erythematosus: a double blind, placebo controlled pilot study.J Rheumatol. 2005 Feb;32(2):275-82. J Rheumatol. 2005. PMID: 15693087 Clinical Trial.
-
The antioxidant alpha-lipoic acid improves endothelial dysfunction induced by acute hyperglycaemia during OGTT in impaired glucose tolerance.Clin Endocrinol (Oxf). 2008 May;68(5):716-23. doi: 10.1111/j.1365-2265.2007.03099.x. Epub 2007 Dec 7. Clin Endocrinol (Oxf). 2008. PMID: 18070144 Clinical Trial.
-
Nitrotyrosine: new findings as a marker of postprandial oxidative stress.Int J Clin Pract Suppl. 2002 Jul;(129):51-8. Int J Clin Pract Suppl. 2002. PMID: 12166608 Review.
-
Protective role of antioxidants in diabetes-induced cardiac dysfunction.Cardiovasc Toxicol. 2010 Jun;10(2):73-86. doi: 10.1007/s12012-010-9064-0. Cardiovasc Toxicol. 2010. PMID: 20458637 Review.
Cited by
-
Postprandial oxidative stress in response to dextrose and lipid meals of differing size.Lipids Health Dis. 2010 Jul 27;9:79. doi: 10.1186/1476-511X-9-79. Lipids Health Dis. 2010. PMID: 20663187 Free PMC article. Clinical Trial.
-
Postprandial Metabolic and Oxidative Stress Responses to Grape Pomace Extract in Healthy Normal and Overweight/Obese Women: A Randomized, Double-Blind, Placebo-Controlled Crossover Study.Nutrients. 2022 Dec 29;15(1):156. doi: 10.3390/nu15010156. Nutrients. 2022. PMID: 36615813 Free PMC article. Clinical Trial.
-
Protection from olanzapine-induced metabolic toxicity in mice by acetaminophen and tetrahydroindenoindole.Int J Obes (Lond). 2010 Jun;34(6):970-9. doi: 10.1038/ijo.2009.291. Epub 2010 Jan 12. Int J Obes (Lond). 2010. PMID: 20065957 Free PMC article.
-
Studies on free radicals, antioxidants, and co-factors.Clin Interv Aging. 2007;2(2):219-36. Clin Interv Aging. 2007. PMID: 18044138 Free PMC article. Review.
-
The Role of Selenium Nanoparticles in Addressing Diabetic Complications: A Comprehensive Study.Curr Top Med Chem. 2024;24(15):1327-1342. doi: 10.2174/0115680266299494240326083936. Curr Top Med Chem. 2024. PMID: 38561614 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous